Search research articles
Contact Us
Filters
Showing results (141-150 of 168) with videos related to
Page
of 17
Sort By:
Breast Cancer Research and Treatment
|
April 21, 2019
Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial)
Jennifer R Bellon, Hao Guo, William T Barry, et al.
NPJ Breast Cancer
|
January 8, 2025
Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER)
Laura M Spring, Lauren Scarpetti, Arielle J Medford, et al.
Breast Cancer Research and Treatment
|
May 19, 2015
Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial)
Kathryn J Ruddy, Hao Guo, William Barry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2022
Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE Trial
Mina S Sedrak, Can-Lan Sun, Jingran Ji, et al.
Therapeutic Advances in Medical Oncology
|
September 2, 2022
Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer
Elyssa Denault, Erika Nakajima, Vivek Naranbhai, et al.
Contemporary Clinical Trials
|
July 28, 2024
Community Collaboration to Advance Racial/Ethnic Equity in Colorectal Cancer Screening: Protocol for a Multilevel Intervention to Improve Screening and Follow-up in Community Health Centers
Folasade P May, Suzanne Brodney, Jessica J Tuan, et al.
Breast Cancer Research and Treatment
|
April 28, 2021
Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens
Beverly Moy, Mafalda Oliveira, Cristina Saura, et al.
JCO Oncology Practice
|
November 3, 2023
Virtual Molecular and Precision Medicine Clinic to Improve Access to Clinical Trials for Patients With Metastatic Breast Cancer: An Academic/Community Collaboration
Laura M Spring, Lindsey Mortensen, Elizabeth Abraham, et al.
Breast Cancer Research : BCR
|
March 15, 2019
PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial
Stephen K L Chia, Miguel Martin, Frankie A Holmes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 10, 2023
Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial
Frankie A Holmes, Beverly Moy, Suzette Delaloge, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 168) with videos related to
Sort By:
Page
of 17
Breast Cancer Research and Treatment
|
April 21, 2019
Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial)
Jennifer R Bellon, Hao Guo, William T Barry, et al.
NPJ Breast Cancer
|
January 8, 2025
Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER)
Laura M Spring, Lauren Scarpetti, Arielle J Medford, et al.
Breast Cancer Research and Treatment
|
May 19, 2015
Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial)
Kathryn J Ruddy, Hao Guo, William Barry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2022
Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE Trial
Mina S Sedrak, Can-Lan Sun, Jingran Ji, et al.
Therapeutic Advances in Medical Oncology
|
September 2, 2022
Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer
Elyssa Denault, Erika Nakajima, Vivek Naranbhai, et al.
Contemporary Clinical Trials
|
July 28, 2024
Community Collaboration to Advance Racial/Ethnic Equity in Colorectal Cancer Screening: Protocol for a Multilevel Intervention to Improve Screening and Follow-up in Community Health Centers
Folasade P May, Suzanne Brodney, Jessica J Tuan, et al.
Breast Cancer Research and Treatment
|
April 28, 2021
Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens
Beverly Moy, Mafalda Oliveira, Cristina Saura, et al.
JCO Oncology Practice
|
November 3, 2023
Virtual Molecular and Precision Medicine Clinic to Improve Access to Clinical Trials for Patients With Metastatic Breast Cancer: An Academic/Community Collaboration
Laura M Spring, Lindsey Mortensen, Elizabeth Abraham, et al.
Breast Cancer Research : BCR
|
March 15, 2019
PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial
Stephen K L Chia, Miguel Martin, Frankie A Holmes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 10, 2023
Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial
Frankie A Holmes, Beverly Moy, Suzette Delaloge, et al.
Page
of 17